Latest

Trackers› Clinical trials› Suzhou

Clinical trial register · China

Clinical Trials in Suzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC

19052

Studies in scope

all four open statuses

11786

Recruiting now

open to new participants

2009

Lead sponsors

across recruiting studies

Top sites

Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343

Trials with a site in Suzhou

Status

Study

Lead sponsor

Phase

Enrol

Chinese sites

Start

Recruiting

Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients

NCT04025450Multiple Myeloma

The First Affiliated Hospital of Soochow University

Phase 1/2

50

Suzhou

2019-07-15

Active, closed

Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)

NCT03932136Clinical High Risk Syndrome of Psychosis

Shanghai Jiao Tong University School of Medicine

Phase 3

300

Guangzhou, Zhengzhou, Changsha, Suzhou, Shanghai, Shenzhen, Tianjin

2019-07-14

Active, closed

Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients

NCT06379360Acute Myeloid Leukemia

The First Affiliated Hospital of Soochow University

Phase 2

60

Suzhou

2019-07-01

Active, closed

Bronchial Ablation for Treatment of Asthma (BATA) Trial

NCT03765307Asthma

SyMap Medical (Suzhou), Ltd.

Not applicable

160

Beijing, Guangzhou, Shenzhen, Shijiazhuang, Qiqihar, Nanjing, Suzhou, Xuzhou

2019-06-18

Recruiting

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

NCT03773965Juvenile Idiopathic Arthritis

Eli Lilly and Company

Phase 3

190

Beijing, Chongqing, Nanjing, Suzhou

2019-04-05

Active, closed

A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

NCT03701334Early Breast Cancer

Novartis Pharmaceuticals

Phase 3

5,101

Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Nanjing, Suzhou, Changchun

2018-12-07

Active, closed

A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma

Astellas Pharma Global Development, Inc.

Phase 3

507

Fuzhou, Haikou, Zhengzhou, Changsha, Hengyang, Suzhou, Wuxi, Hangzhou

2018-11-28

Active, closed

A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.

NCT03539744Multiple Myeloma

AbbVie

Phase 3

265

Beijing, Guangzhou, Zhengzhou, Wuhan, Nanjing, Suzhou, Nanchang, Shenyang

2018-10-22

Active, closed

A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Takeda

Phase 3

245

Zhengzhou, Suzhou, Changchun, Hangzhou, Tianjin

2018-10-04

Recruiting

Nutritional Status of Patients After Hematopoietic Stem Cell Transplantation

NCT04146870Nutrition, Hematopoietic Stem Cell Transplantation

The First Affiliated Hospital of Soochow University

Observational

200

Suzhou

2018-10-01

Recruiting

Hypofractionated Vs Conventional Fractionated Radiotherapy After Breast Conserving Surgery

NCT04025164Breast Cancer

Fudan University

Not applicable

4,052

Guiyang, Suzhou, Dalian, Shanghai

2018-07-01

Active, closed

Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT

NCT03455972Safety and Efficacy

The First Affiliated Hospital of Soochow University

Phase 1/2

43

Suzhou

2018-02-20

Active, closed

CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia

NCT03984968Acute Lymphoblastic Leukemia, Adult B-Cell

The First Affiliated Hospital of Soochow University

Phase 1/2

40

Suzhou

2017-07-10

Recruiting

FMT in Gut aGVHD Treated

NCT03148743Acute-graft-versus-host Disease

The First Affiliated Hospital of Soochow University

Observational

50

Suzhou

2017-05-16

Recruiting

Study of T Cells Targeting CD138/BCMA/CD19/More Antigens (CART-138/BCMA/19/More) for Chemotherapy Refractory and Relapsed Multiple Myeloma

NCT03196414Multiple Myeloma

The First Affiliated Hospital of Soochow University

Phase 1/2

10

Suzhou

2016-09

Active, closed

Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer

NCT02455141Breast Neoplasm

Shanghai Jiao Tong University School of Medicine

Phase 3

786

Fuding, Fuzhou, Quanzhou, Foshan, Guangzhou, Harbin, Jiangyin, Suzhou

2016-03

Active, closed

CAR-T Cell Therapy Targeting to CD19 for R/R ALL

NCT03919240Acute Lymphoblastic Leukemia With Failed Remission

The First Affiliated Hospital of Soochow University

Phase 1/2

196

Suzhou

2015-12-01

Active, closed

Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]

NCT02486718Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 3

1,280

Beijing, Guangzhou, Hangzhou, Hefei, Shanghai, Shengyang, Shenyang, Suzhou

2015-10-31

Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma

Janssen Research & Development, LLC

Phase 3

700

Beijing, Chengdu, Fuzhou, Guangzhou, Hangzhou, Shanghai, Shanxi, Suzhou

2013-09-09

By invitation

Follow-up Study of ICUS and CCUS Patients

NCT04428489Myelodysplastic Syndromes

The First Affiliated Hospital of Soochow University

Observational

300

Suzhou

2011-01-01

Recruiting

"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu

NCT03097952Hepatitis B， Chronic

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Observational

20,000

Changzhou, Huai'an, Nanjing, Suqian, Suzhou

2008-01

Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/suzhou?page=5

Query this register directly

GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 421 of those studies with a site in Suzhou.

How many clinical trials are recruiting in Suzhou?

269 of the 421 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 53 have not yet opened recruitment, 87 are active but closed to new participants, and 12 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.